Hmmm so Genentech is out to end of 2019 now to make a decision ?
And they’ve gone back to soley discovery phase & not taking anything pre-clinical ?
I don’t know but to me that looks like they’re still trying to avoid the long elusive pk/pd staying in discovery & imagine thats always what pharma have been looking for to get a bigger deal than all the previous ones to date - so still in the same place ?
but what would i know
Ann: PYC Pivot to Platform - BioShowcase Presentation, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |